HCPCS Level II · Drugs administered other than oral method
J3380Injection, vedolizumab, intravenous, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J3380
J3380 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, vedolizumab, intravenous, 1 mg.
It was added to HCPCS effective 01/01/2016, and its current record took effect 04/01/2024.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj vedolizumab iv 1 mg
- Date added
- 01/01/2016
- Action effective
- 04/01/2024
- BETOS
- O1E
Related J33xx codes
- J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302Injection, triamcinolone diacetate, per 5 mg
- J3303Injection, triamcinolone hexacetonide, per 5 mg
- J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3315Injection, triptorelin pamoate, 3.75 mg
- J3316Injection, triptorelin, extended-release, 3.75 mg
- J3350Injection, urea, up to 40 gm
- J3357Ustekinumab, for subcutaneous injection, 1 mg
- J3358Ustekinumab, for intravenous injection, 1 mg
- J3360Injection, diazepam, up to 5 mg
- J3373Injection, vancomycin hydrochloride, 10 mg
Common questions about J3380
Is HCPCS J3380 still valid?
- Yes. J3380 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J3380?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.